Spots Global Cancer Trial Database for epidermal growth factor
Every month we try and update this database with for epidermal growth factor cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Topotecan and Gefitinib (Iressa) for Ovarian, Peritoneal, or Fallopian Tube Cancer | NCT00317772 | Ovarian Cancer Peritoneal Neop... Fallopian Tube ... | Topotecan Gefitinib | - | M.D. Anderson Cancer Center | |
| Topotecan and Gefitinib (Iressa) for Ovarian, Peritoneal, or Fallopian Tube Cancer | NCT00317772 | Ovarian Cancer Peritoneal Neop... Fallopian Tube ... | Topotecan Gefitinib | - | M.D. Anderson Cancer Center | |
| Radiation Therapy and Bortezomib and Cetuximab With or Without Cisplatin to Treat Head and Neck Cancer | NCT01445405 | Carcinoma, Squa... Head and Neck C... Oral Cancer Laryngeal Cance... Pharyngeal Canc... | Bortezomib (Vel... Cetuximab Cisplatin Radiation Thera... | 18 Years - 90 Years | National Institutes of Health Clinical Center (CC) | |
| The Effect of Intravenous Lidocaine on THBS2 and Angiogenic Factors Expression in Women Undergoing Cervical Cancer Surgery | NCT05560035 | Cervical Cancer Metastatic Canc... | Lidocaine Normal saline (... | 18 Years - 65 Years | General Hospital of Ningxia Medical University | |
| The Effect of Intravenous Lidocaine on THBS2 and Angiogenic Factors Expression in Women Undergoing Cervical Cancer Surgery | NCT05560035 | Cervical Cancer Metastatic Canc... | Lidocaine Normal saline (... | 18 Years - 65 Years | General Hospital of Ningxia Medical University | |
| Angiogenic and EGFR Blockade With Curative Chemoradiation for Advanced Head and Neck Cancer | NCT00140556 | Head and Neck C... Pharynx Cancer | Chemoradiothera... Cisplatin Bevacizumab Erlotinib | 18 Years - | Duke University | |
| High Dose Gefitinib for the Treatment of Carcinomatous Meningitis in Adult Patients With Non-Small Cell Lung Cancer and Known or Suspected EGFR Mutations | NCT00372515 | Non-Small Cell ... | Gefitinib | 18 Years - | Dana-Farber Cancer Institute | |
| Radiotherapy Plus Panitumumab Compared to Chemoradiotherapy With Unresected, Locally Advanced Squamous Cell Carcinoma of the Head and Neck | NCT00547157 | Cancer Head and Neck C... Oncology Squamous Cell C... | Panitumumab Cisplatin | 18 Years - | Amgen | |
| Assessment of EGFR Genomic Alterations as Prognostic Markers in Cervical Cancer | NCT00298064 | Cervical Cancer Cervix | Tissue Reposito... | - | University of New Mexico | |
| The Effect of Intravenous Lidocaine on THBS2 and Angiogenic Factors Expression in Women Undergoing Cervical Cancer Surgery | NCT05560035 | Cervical Cancer Metastatic Canc... | Lidocaine Normal saline (... | 18 Years - 65 Years | General Hospital of Ningxia Medical University | |
| Panitumumab in Children With Solid Tumors | NCT00658658 | Solid Tumors | Panitumumab | 1 Year - 17 Years | Amgen | |
| The Role of Gene Changes in Brain Tumor Formation and Growth | NCT00059020 | Glioma | - | National Institutes of Health Clinical Center (CC) | ||
| Panitumumab in Children With Solid Tumors | NCT00658658 | Solid Tumors | Panitumumab | 1 Year - 17 Years | Amgen | |
| Topotecan and Gefitinib (Iressa) for Ovarian, Peritoneal, or Fallopian Tube Cancer | NCT00317772 | Ovarian Cancer Peritoneal Neop... Fallopian Tube ... | Topotecan Gefitinib | - | M.D. Anderson Cancer Center | |
| Radiotherapy Plus Panitumumab Compared to Chemoradiotherapy With Unresected, Locally Advanced Squamous Cell Carcinoma of the Head and Neck | NCT00547157 | Cancer Head and Neck C... Oncology Squamous Cell C... | Panitumumab Cisplatin | 18 Years - | Amgen |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
